Abano Terme, Italy

Stefano Pluda

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Fidia Farmaceutici S.p.a.. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefano Pluda

Introduction

Stefano Pluda is a notable inventor based in Abano Terme, Italy. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work with hyaluronic acids. His research and inventions have the potential to impact various medical applications.

Latest Patents

Stefano Pluda holds a patent for "Sulphated hyaluronic acids functionalised with dopamine." This patent discloses a grade 2 sulphated hyaluronic acid that contains 2 to 60% molar of carboxyl groups functionalized with dopamine. The functionalization is achieved either directly via an amide bond or through a spacer with an amino group, facilitating the formation of an amide bond with the carboxyl groups of hyaluronic acid.

Career Highlights

Stefano Pluda is associated with Fidia Farmaceutici S.p.a., a company known for its focus on innovative pharmaceutical solutions. His work at Fidia has allowed him to explore and develop new applications for hyaluronic acid, contributing to advancements in the field.

Collaborations

Stefano has collaborated with notable coworkers such as Cristian Guarise and Devis Galesso. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Stefano Pluda's contributions to the field of pharmaceuticals through his patent on sulphated hyaluronic acids functionalised with dopamine exemplify his innovative spirit. His work continues to pave the way for advancements in medical applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…